Asensus Surgical Announces 510(k) Submission to FDA for Machine Vision Capabilities Expansion
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced that it has filed a 510 (k) submission with the FDA for an expansion of capabilities on the previously cleared Intelligent Surgical Unit™ (ISU™).
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced that it has filed a 510 (k) submission with the FDA for an expansion of capabilities on the previously cleared Intelligent Surgical Unit™ (ISU™).
patient, expansion, FDA, submission, 510 (k, medical device company, Intelligent Surgical Unit™, capabilities, Asensus Surgical, new era, Guided Surgery™, Inc, ASXC, interface, surgeon, NYSE American, ISU™
